Logo image of MODV

MODIVCARE INC (MODV) Stock Fundamental Analysis

NASDAQ:MODV - Nasdaq - US60783X1046 - Common Stock - Currency: USD

3.21  -0.52 (-13.94%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MODV. MODV was compared to 103 industry peers in the Health Care Providers & Services industry. MODV may be in some trouble as it scores bad on both profitability and health. MODV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year MODV has reported negative net income.
In the past year MODV has reported a negative cash flow from operations.
In the past 5 years MODV reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MODV reported negative operating cash flow in multiple years.
MODV Yearly Net Income VS EBIT VS OCF VS FCFMODV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

MODV's Return On Assets of -13.68% is on the low side compared to the rest of the industry. MODV is outperformed by 81.55% of its industry peers.
MODV has a Return On Invested Capital (0.67%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for MODV is significantly below the industry average of 9.71%.
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROIC 0.67%
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
MODV Yearly ROA, ROE, ROICMODV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400

1.3 Margins

MODV has a Operating Margin of 0.42%. This is comparable to the rest of the industry: MODV outperforms 41.75% of its industry peers.
MODV's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 15.15%, MODV is doing worse than 66.99% of the companies in the same industry.
MODV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.42%
PM (TTM) N/A
GM 15.15%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
MODV Yearly Profit, Operating, Gross MarginsMODV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

0

2. Health

2.1 Basic Checks

MODV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MODV has more shares outstanding
Compared to 5 years ago, MODV has more shares outstanding
Compared to 1 year ago, MODV has a worse debt to assets ratio.
MODV Yearly Shares OutstandingMODV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MODV Yearly Total Debt VS Total AssetsMODV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MODV has an Altman-Z score of 1.36. This is a bad value and indicates that MODV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MODV (1.36) is worse than 66.02% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACC0.12
WACC5.55%
MODV Yearly LT Debt VS Equity VS FCFMODV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.80 indicates that MODV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.80, MODV is doing worse than 80.58% of the companies in the same industry.
A Quick Ratio of 0.80 indicates that MODV may have some problems paying its short term obligations.
With a Quick ratio value of 0.80, MODV is not doing good in the industry: 73.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
MODV Yearly Current Assets VS Current LiabilitesMODV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

MODV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.76%.
Measured over the past years, MODV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.09% on average per year.
The Revenue has decreased by -0.70% in the past year.
The Revenue has been growing by 13.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%

3.2 Future

The Earnings Per Share is expected to grow by 19.50% on average over the next years. This is quite good.
The Revenue is expected to grow by 0.26% on average over the next years.
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MODV Yearly Revenue VS EstimatesMODV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
MODV Yearly EPS VS EstimatesMODV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

MODV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MODV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MODV Price Earnings VS Forward Price EarningsMODV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

MODV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MODV is cheaper than 79.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.13
MODV Per share dataMODV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

MODV's earnings are expected to grow with 19.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-100.18%
EPS Next 3Y19.5%

0

5. Dividend

5.1 Amount

No dividends for MODV!.
Industry RankSector Rank
Dividend Yield N/A

MODIVCARE INC

NASDAQ:MODV (7/11/2025, 8:00:00 PM)

3.21

-0.52 (-13.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners97.11%
Inst Owner Change0%
Ins Owners0.87%
Ins Owner Change-8.77%
Market Cap46.06M
Analysts47.5
Price Target1.2 (-62.62%)
Short Float %20.34%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-114.73%
Min EPS beat(2)-235.29%
Max EPS beat(2)5.84%
EPS beat(4)1
Avg EPS beat(4)-94.09%
Min EPS beat(4)-235.29%
Max EPS beat(4)5.84%
EPS beat(8)2
Avg EPS beat(8)-63.41%
EPS beat(12)4
Avg EPS beat(12)-37.21%
EPS beat(16)8
Avg EPS beat(16)-21.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)-1.23%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-3.73%
Max Revenue beat(4)-1.23%
Revenue beat(8)2
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.97%
Revenue beat(16)7
Avg Revenue beat(16)0.31%
PT rev (1m)-80.21%
PT rev (3m)-78.44%
EPS NQ rev (1m)-10900%
EPS NQ rev (3m)-191.89%
EPS NY rev (1m)-18.47%
EPS NY rev (3m)-1680.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.13
EPS(TTM)-1.1
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-8.49
FCFYN/A
OCF(TTM)-6.83
OCFYN/A
SpS191.9
BVpS-6.11
TBVpS-72.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.68%
ROE N/A
ROCE 1.14%
ROIC 0.67%
ROICexc 0.73%
ROICexgc 3.11%
OM 0.42%
PM (TTM) N/A
GM 15.15%
FCFM N/A
ROA(3y)-8.46%
ROA(5y)-4.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.96%
ROIC(5y)3.81%
ROICexc(3y)2.01%
ROICexc(5y)4.28%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.56%
ROCE(5y)4.87%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-39.44%
ROICexc growth 5Y-26.6%
OM growth 3Y-52.57%
OM growth 5Y-22.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.08%
GM growth 5Y14.43%
F-Score3
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.6
Cap/Depr 22.51%
Cap/Sales 0.87%
Interest Coverage 0.11
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 1.36
F-Score3
WACC5.55%
ROIC/WACC0.12
Cap/Depr(3y)32.88%
Cap/Depr(5y)36.51%
Cap/Sales(3y)1.28%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.76%
EPS 3Y-59.43%
EPS 5Y-21.09%
EPS Q2Q%-1800%
EPS Next Y-647.27%
EPS Next 2Y-100.18%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.7%
Revenue growth 3Y11.76%
Revenue growth 5Y13.05%
Sales Q2Q%-4.94%
Revenue Next Year-5.24%
Revenue Next 2Y-0.3%
Revenue Next 3Y0.26%
Revenue Next 5YN/A
EBIT growth 1Y-59.03%
EBIT growth 3Y-46.99%
EBIT growth 5Y-12.71%
EBIT Next Year218.72%
EBIT Next 3Y52.2%
EBIT Next 5YN/A
FCF growth 1Y0.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.91%
OCF growth 3YN/A
OCF growth 5YN/A